Keyword Search Results for "anti-anginal"

Morrow, D. A., Scirica, B. M., Karwatowska-Prokopczuk, E., Skene, A., McCabe, C. H., Braunwald, E. Evaluation of a novel anti-ischemic agent in acute coronary syndromes: design and rationale for the Metabolic Efficiency with Ranolazine for Less Ischemia in Non-ST-elevation acute coronary syndromes (MERLIN)-TIMI 36 trial Am Heart J. 2006;151(6):1186 e1-9. Abstract

Scirica, B. M., Morrow, D. A., Hod, H., Murphy, S. A., Belardinelli, L., Hedgepeth, C. M., Molhoek, P., Verheugt, F. W., Gersh, B. J., McCabe, C. H., Braunwald, E. Effect of ranolazine, an antianginal agent with novel electrophysiological properties, on the incidence of arrhythmias in patients with non ST-segment elevation acute coronary syndrome: results from the Metabolic Efficiency With Ranolazine for Less Ischemia in Non ST-Elevation Acute Coronary Syndrome Thrombolysis in Myocardial Infarction 36 (MERLIN-TIMI 36) randomized controlled trial Circulation. 2007;116(15):1647-52. Abstract

Arnold, S. V., Morrow, D. A., Wang, K., Lei, Y., Mahoney, E. M., Scirica, B. M., Braunwald, E., Cohen, D. J. Effects of ranolazine on disease-specific health status and quality of life among patients with acute coronary syndromes: results from the MERLIN-TIMI 36 randomized trial Circ Cardiovasc Qual Outcomes. 2008;1(2):107-15. Abstract

Morrow, D. A., Scirica, B. M., Chaitman, B. R., McGuire, D. K., Murphy, S. A., Karwatowska-Prokopczuk, E., McCabe, C. H., Braunwald, E. Evaluation of the glycometabolic effects of ranolazine in patients with and without diabetes mellitus in the MERLIN-TIMI 36 randomized controlled trial Circulation. 2009;119(15):2032-9. Abstract

Scirica, B. M., Morrow, D. A., Budaj, A., Dalby, A. J., Mohanavelu, S., Qin, J., Aroesty, J., Hedgepeth, C. M., Stone, P. H., Braunwald, E. Ischemia detected on continuous electrocardiography after acute coronary syndrome: observations from the MERLIN-TIMI 36 (Metabolic Efficiency With Ranolazine for Less Ischemia in Non-ST-Elevation Acute Coronary Syndrome-Thrombolysis In Myocardial Infarction 36) trial Journal of the American College of Cardiology. 2009;53(16):1411-21. Abstract

Wilson, S. R., Scirica, B. M., Braunwald, E., Murphy, S. A., Karwatowska-Prokopczuk, E., Buros, J. L., Chaitman, B. R., Morrow, D. A. Efficacy of ranolazine in patients with chronic angina observations from the randomized, double-blind, placebo-controlled MERLIN-TIMI (Metabolic Efficiency With Ranolazine for Less Ischemia in Non-ST-Segment Elevation Acute Coronary Syndromes) 36 Trial Journal of the American College of Cardiology. 2009;53(17):1510-6. Abstract

Bonaca, Marc P., Kudinova, Anastacia, Kakkar, Rahul, Scirica, Benjamin S., Sabatine, Marc S., Murphy, Sabina A., Braunwald, Eugene, Lee, Richard T., Morrow, David A. ST2 and the Risk of CV Death or Heart Failure in Patients with Non-ST elevation Acute Coronary Syndromes (NSTE-ACS): Observations from MERLIN-TIMI 36 Circulation. 2010;122(21):NA.

Bonaca, Marc P., Scirica, Bejamin M., Sabatine, Marc S., Jarolim, Petr, Murphy, Sabina A., Chamberlin, Janna S., Rhodes, Daniel W., Southwick, Paula C., Braunwald, Eugene, Morrow, David A. Metalloproteinase PAPP-A and Outcomes in Patients with ACS: Observations from the MERLIN-TIMI 36 Trial Circulation. 2010;122(21):NA.

Mega, J. L., Hochman, J. S., Scirica, B. M., Murphy, S. A., Sloan, S., McCabe, C. H., Merlini, P., Morrow, D. A. Clinical features and outcomes of women with unstable ischemic heart disease: observations from metabolic efficiency with ranolazine for less ischemia in non-ST-elevation acute coronary syndromes-thrombolysis in myocardial infarction 36 (MERLIN-TIMI 36) Circulation. 2010;121(16):1809-17. Abstract

Morrow, D. A., Scirica, B. M., Sabatine, M. S., de Lemos, J. A., Murphy, S. A., Jarolim, P., Theroux, P., Bode, C., Braunwald, E. B-type natriuretic peptide and the effect of ranolazine in patients with non-ST-segment elevation acute coronary syndromes: observations from the MERLIN-TIMI 36 (Metabolic Efficiency With Ranolazine for Less Ischemia in Non-ST Elevation Acute Coronary-Thrombolysis In Myocardial Infarction 36) trial Journal of the American College of Cardiology. 2010;55(12):1189-96. Abstract

Syed, Zeeshan, Scirica, Benjamin M., Mohanavelu, Satishkumar, Morrow, David A., Stultz, Collin M., Guttag, John Association of Heart Rate Turbulence, Deceleration Capacity and Morphologic Variability with Sudden Cardiac Death Following Non-ST-Elevation Acute Coronary Syndrome: Results from the MERLIN-TIMI 36 Trial Circulation. 2010;122(21):NA.

Harkness, J. R., Morrow, D. A., Braunwald, E., Ren, F., Lopez-Sendon, J., Bode, C., Budaj, A., Scirica, B. M. Myocardial ischemia and ventricular tachycardia on continuous electrocardiographic monitoring and risk of cardiovascular outcomes after non-ST-segment elevation acute coronary syndrome (from the MERLIN-TIMI 36 Trial) American journal of cardiology. 2011;108(10):1373-81. Abstract

Scirica, B. M., Sabatine, M. S., Jarolim, P., Murphy, S. A., de Lemos, J. L., Braunwald, E., Morrow, D. A. Assessment of multiple cardiac biomarkers in non-ST-segment elevation acute coronary syndromes: observations from the MERLIN-TIMI 36 trial European heart journal. 2011;32(6):697-705. Abstract

Bonaca, M. P., Scirica, B. M., Sabatine, M. S., Jarolim, P., Murphy, S. A., Chamberlin, J. S., Rhodes, D. W., Southwick, P. C., Braunwald, E., Morrow, D. A. Prospective evaluation of pregnancy-associated plasma protein-a and outcomes in patients with acute coronary syndromes J Am Coll Cardiol. 2012;60(4):332-8. Abstract

O'Malley, Ryan G., Bonaca, Marc, Sabatine, Marc, Scirica, Benjamin, Jarolim, Petr, Conrad, Michael, Murphy, Sabina, Braunwald, Eugene, Morrow, David PROGNOSTIC PERFORMANCE OF A SINGLE-MOLECULE HIGH-SENSITIVITY CARDIAC TROPONIN ASSAY AFTER NON-ST ELEVATION ACUTE CORONARY SYNDROME: ANALYSIS FROM MERLIN-TIMI 36 Journal of the American College of Cardiology. 2012;59(13):E402-E402.

Udell, Jacob A, Bonaca, Marc P, Braunwald, Eugene, Hoffman, Elain P, Mohanavelu, Satishkumar, Jarolim, Petr, Michael, Conrad J, Desai, Nihar R, Sabatine, Marc S, Morrow, David A, Scirica, Benjamin M Abstract 11434: Low Level Elevation of Highly-Sensitive Cardiac Troponin I after Non-ST Elevation Acute Coronary Syndrome and Early Risk of Cardiac Ischemia and Ventricular Tachycardia: Analysis from MERLIN-TIMI 36 Circulation. 2012;126(21 Supplement):A11434.

Golwala, H. B., Thadani, U., Liang, L., Stavrakis, S., Butler, J., Yancy, C. W., Bhatt, D. L., Hernandez, A. F., Fonarow, G. C. Use of hydralazine-isosorbide dinitrate combination in african american and other race/ethnic group patients with heart failure and reduced left ventricular ejection fraction J Am Heart Assoc. 2013;2(4):e000214. Abstract

Scirica, B., Nieminen, T., Pegler, J. R. M., Tavares, C., Pagotto, V. P. F., Kanas, A. F., Sobrado, M. F., Nearing, B., Cho, J. I., Morrow, D., Belardinelli, L., Verrier, R., Harvard Medical School T-Wave Alternans (TWA) is Associated with Cardiovascular Mortality and NSVTin the MERLIN-TIMI 36 Trial of Ranolazine versus Placebo in Patients with Non-ST Segment Elevation Acute Coronary Syndrome Journal of the American College of Cardiology. 2013;61(10):64.

May, Erin Ann Bohula, Bonaca, Marc, Scirica, Benjamin, Kuder, Julia, Murphy, Sabina, Jarolim, Petr, Sabatine, Marc, Morrow, David GROWTH DIFFERENTIATION FACTOR-15 LEVEL PREDICTS RECURRENT CARDIOVASCULAR EVENTS IN PATIENTS WITH AN ACUTE CORONARY SYNDROME IN MERLIN-TIMI 36 Journal of the American College of Cardiology. 2014;63(12, Supplement):A20.

Nieminen, T., Scirica, B. M., Pegler, J. R., Tavares, C., Pagotto, V. P., Kanas, A. F., Sobrado, M. F., Nearing, B. D., Umez-Eronini, A. A., Morrow, D. A., Belardinelli, L., Verrier, R. L. Relation of T-Wave Alternans to Mortality and Nonsustained Ventricular Tachycardia in Patients With Non-ST-Segment Elevation Acute Coronary Syndrome from the MERLIN-TIMI 36 Trial of Ranolazine Versus Placebo Am J Cardiol. 2014;NA(NA):NA. Abstract

O'Malley, R. G., Bonaca, M. P., Scirica, B. M., Murphy, S. A., Jarolim, P., Sabatine, M. S., Braunwald, E., Morrow, D. A. Prognostic Performance of Multiple Biomarkers in Patients With Non-ST-Segment Elevation Acute Coronary Syndrome: Analysis From the MERLIN-TIMI 36 Trial (Metabolic Efficiency With Ranolazine for Less Ischemia in Non-ST-Elevation Acute Coronary Syndromes-Thrombolysis In Myocardial Infarction 36) J Am Coll Cardiol. 2014;63(16):1644-53. Abstract